Bolt Biotherapeutics, Inc.
USD5.11
-0.20 (-3.77%)
CEO
William Quinn
IPO Date
2021-02-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$5.36
Prev. Close
$5.31
Day Low
$4.98
Day High
$5.36
52W Low
$3.91
52W High
$7.35
Market Cap
$0.01B
Volume
0.01M
| 20,000 |
| $6.71 |
| 4 Feb 2026 | Yonehiro Grant | Chief Operating Officer | A-Award | Acquired | 10,000 | $6.71 |
| 4 Feb 2026 | Nemec Sarah | Senior VP, Finance and PAO | P-Purchase | Acquired | 125 | $4.61 |
| 4 Feb 2026 | Nemec Sarah | Senior VP, Finance and PAO | A-Award | Acquired | 8,000 | $6.71 |
| 16 Dec 2025 | Dupont Jakob | director | A-Award | Acquired | 2,500 | $5.44 |
| 16 Dec 2025 | Dupont Jakob | director | D-Return | Disposed | 849 | $13.60 |
| 16 Dec 2025 | Dupont Jakob | director | A-Award | Acquired | 849 | $5.44 |
| 16 Dec 2025 | Dupont Jakob | director | A-Award | Acquired | 1,000 | $5.44 |
| 16 Dec 2025 | Dupont Jakob | director | D-Return | Disposed | 1,000 | $7.02 |